June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Toric IOL implantation during phacoemulsification and trabeculectomy combined procedures: One year follow up results.
Author Affiliations & Notes
  • Gian Franco Díez
    Asociación Para Evitar la Ceguera en México, México City, Mexico
  • Rafael Castañeda-Díez
    Asociación Para Evitar la Ceguera en México, México City, Mexico
  • Jesús Jiménez-Román
    Asociación Para Evitar la Ceguera en México, México City, Mexico
  • Angela María Garcés-Valencia
    Asociación Para Evitar la Ceguera en México, México City, Mexico
  • Carolina Prado
    Asociación Para Evitar la Ceguera en México, México City, Mexico
  • Sandra Karina Silva-Romano
    Asociación Para Evitar la Ceguera en México, México City, Mexico
  • María Luisa Zavala Aznar
    Asociación Para Evitar la Ceguera en México, México City, Mexico
  • Footnotes
    Commercial Relationships Gian Franco Díez, None; Rafael Castañeda-Díez, None; Jesús Jiménez-Román, None; Angela María Garcés-Valencia, None; Carolina Prado, None; Sandra Karina Silva-Romano, None; María Luisa Zavala Aznar, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2663. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Gian Franco Díez, Rafael Castañeda-Díez, Jesús Jiménez-Román, Angela María Garcés-Valencia, Carolina Prado, Sandra Karina Silva-Romano, María Luisa Zavala Aznar; Toric IOL implantation during phacoemulsification and trabeculectomy combined procedures: One year follow up results.. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2663.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: <br /> To evaluate the keratometric, refractive and visual outcomes in glaucoma patients who underwent phacoemulsification with toric intraocular lens implant and trabeculectomy assisted with femtosecond laser technology.

Methods: <br /> A prospective, longitudinal and interventional study design in which seven glaucoma patients, with astigmatism over 1 diopter, candidates for cataract phacoemulsification and trabeculectomy without MMC where operated using femtosecond laser technology (Alcon LenSx) with toric intraocular lens (IOL SN6A T3-T6) implantation by one surgeon (RCD). Toric IOL power was calculated using the online calculator provided by the manufacturer considering the average induced astigmatism of the surgeon (-0.43± 0.43 D). Follow up visits were appointed at 1, 3, 6 and 12 months after the procedure; keratometric and refractive astigmatism, visual acuity and intraocular pressure were assessed on months 3 and 12.

Results: <br /> Seven eyes of seven patients were included (3 male; 4 female) of which 5 patients completed follow up. Mean age was 71.7 (±7.65 DS; range 58-80). Mean uncorrected visual acuity (UCAV) was 0.31 and 0.2 LogMar at 3 and 12 months respectively with statistically significant improvement (p= 0.024). Best corrected visual acuity (BCVA) was 0.11 and 0.4 (±0.2 DS) LogMar at 3 and 12 months follow up. The mean keratometric astigmatism was found to be -1.64 at the 3 month interval and -1.95 (±0.97 DS) at 12 months, with a mean axis of 92.860 and 790 (± 31.1 DS), respectively. Mean refractive astigmatism was 1.11 and -0.85 (±0.85 DS) at 3 and 12 months; with a mean axis of 57.140 at 3 months and 410 (±37.64 DS) a year after the surgery. Mean IOP measurements were 14 mmHg at 3 months the and 10 mmHg one year after the surgery.

Conclusions: <br /> There was improvement of visual acuity and lower IOP levels at 3 and 12 months follow up of patients implanted with toric IOL during phacoemulsification and trabeculectomy surgery assisted with femtosecond laser. Four out of the five patients with complete follow-up registered lower refractive astigmatism on the last visit.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×